Parkman Healthcare Partners LLC - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 80 filers reported holding HARVARD BIOSCIENCE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Parkman Healthcare Partners LLC ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2022$782,000
-38.2%
305,353
-13.2%
0.22%
-52.4%
Q2 2022$1,266,000
-67.8%
351,750
-44.5%
0.47%
-59.5%
Q1 2022$3,936,000
+4.0%
633,826
+18.0%
1.15%
+38.0%
Q4 2021$3,786,000
+14.1%
537,081
+13.0%
0.84%
-0.5%
Q3 2021$3,318,000
-1.0%
475,367
+18.1%
0.84%
+14.5%
Q2 2021$3,352,000402,3670.73%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q3 2022
NameSharesValueWeighting ↓
Harvey Partners, LLC 790,000$2,378,0003.09%
Alambic Investment Management, L.P. 25,398$76,0000.83%
Adirondack Research & Management Inc. 190,494$573,0000.80%
Archon Capital Management LLC 881,794$2,654,0000.53%
BARD ASSOCIATES INC 1,483,610$4,465,0000.47%
DALTON GREINER HARTMAN MAHER & CO 909,977$2,739,0000.45%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 1,537,800$4,629,0000.40%
Portolan Capital Management 979,067$2,947,0000.33%
HEARTLAND ADVISORS INC 961,400$2,894,0000.25%
Granahan Investment Management 1,757,176$5,289,0000.18%
View complete list of HARVARD BIOSCIENCE INC shareholders